Results 161 to 170 of about 12,803 (222)

Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol \u2014 United States, May\u2013August 2022

open access: yes
What is already known about this topic? Tecovirimat (Tpoxx) was approved by the Food and Drug Administration for treatment of smallpox based on data obtained from animal models; there are no safety or efficacy data regarding its use in patients with ...

core  

Discovery of potential antiviral compounds and accelerating the therapeutic discovery against monkeypox virus. [PDF]

open access: yesSci Rep
Ahmad F   +7 more
europepmc   +1 more source

Insights into Genomic Dynamics and Plasticity in the Monkeypox Virus from the 2022 Outbreak. [PDF]

open access: yesInt J Mol Sci
Deiana M   +14 more
europepmc   +1 more source

Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom. [PDF]

open access: yesEmerg Infect Dis
Sheridan VH   +6 more
europepmc   +1 more source

Monkeypox virus protein OPG188 antagonizes cGAS-STING antiviral signaling pathway to mediate immune evasion. [PDF]

open access: yesProc Natl Acad Sci U S A
Pan Z   +17 more
europepmc   +1 more source

Disentangling Temporal Trends of Clade Ib Monkeypox Virus Transmission in Burundi. [PDF]

open access: yesJ Infect Dis
Jin S   +10 more
europepmc   +1 more source

Monkeypox Virus Shedding Despite Tecovirimat Treatment in a Cohort in Toronto, Canada. [PDF]

open access: yesJ Infect Dis
Hurst JR   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy